Overall survival, disease-specific survival and local recurrence outcomes in patients with muscle-invasive bladder cancer treated with external beam radiotherapy and brachytherapy: a systematic review.
Liam MannionCecilia BoscoRajesh NairVinod MullasseryDeborah EntingEmma-Louise JonesMieke Van HemelrijckSimon HughesPublished in: BJU international (2020)
Brachytherapy as part of CMT for MIBC is not a standard technique. It is an effective treatment in experienced centres for a selected patient population who wish to preserve their bladder. In such patients, CMT-BT is well tolerated with an acceptable safety profile.
Keyphrases
- radiation therapy
- high dose
- muscle invasive bladder cancer
- end stage renal disease
- locally advanced
- free survival
- newly diagnosed
- ejection fraction
- chronic kidney disease
- spinal cord injury
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- low dose
- type diabetes
- rectal cancer
- patient reported outcomes
- radiation induced
- insulin resistance
- skeletal muscle
- replacement therapy
- smoking cessation